We've got another reminder that when Uncle Sam comes knocking on a company's front door,

it's not to give them candy and flowers.

Motley Fool Money starts now.

I'm Chris Hill and joining me back by popular demand.

Motley Fool Senior and Les Bill Man.

Thanks for being here.

Can't get rid of me, Kenya.

Let me just pull back to curtain for the dozens of listeners.

Sometimes, it doesn't happen often, but sometimes there's a miscommunication in scheduling.

And the analysts who schedule just kind of falls through.

And then you go to the emergency route and call up Bill Man.

And say, Bill, need you back on the show.

And given that I don't know what I'm talking about in the best of times, I'm ready.

I think you're going to have informed opinions and analysis on this story, because this

is a pretty big story, which is that the US Food and Drug Administration is preparing

to order jewel labs to take its e-cigarettes off the market here in the US.

The Wall Street Journal is reporting this.

We'll see if the actual ruling comes down by the time this episode gets published.

Altria Group has a 35% stake in jewel labs and not surprisingly shares of Altria down

8.5% on this news, which for a stock like Altria, not historically a big mover day-to-day

in either direction, pretty significant drop.

I find it amazing in this country that jewel, that jewel-e-cigarettes may actually be made

...